Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.
about
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group studyLaparoscopic optical coherence tomography imaging of human ovarian cancer.Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer Detection.The preclinical natural history of serous ovarian cancer: defining the target for early detectionAcceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.Laparoscopic management of adnexal masses the opportunities and the risks.Clinical management of BRCA1 and BRCA2 mutation carriers.Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.Surveillance of women at high risk for hereditary ovarian cancer is inefficient.Opportunistic salpingectomy for ovarian cancer preventionNew insights into the pathogenesis of serous ovarian cancer and its clinical impactVitamin A metabolism is impaired in human ovarian cancer.Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.Genetic risk and gynecologic cancers.Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2."Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty".Risk-Reducing Salpingo-Oophorectomy for the Prevention of Inherited Breast and Ovarian Cancer
P2860
Q30370475-B56307E9-5618-42CA-80C5-F67064184BA1Q30431721-3016ECCD-CCF6-4EF3-9439-5ECA30D6D348Q30499394-E5165F75-85B9-40EE-856F-5A1C2CCDB6C5Q30701684-085A4398-9EB5-4AC7-A731-6273368FA706Q33487678-5FDF66D1-7B0F-4B4B-A99F-8CEF49B20D16Q33668934-0B8AA316-9A3E-4E21-8045-D85DBA421F5FQ34125241-E4CA432A-8262-4E8B-B38C-0C9B3721194DQ34172655-BC3F0690-4134-4BC9-AEF9-E2B5437C7712Q34313361-8C9B5BF2-1738-420F-B6E8-52B37086FD1DQ34397244-A5BE6469-C701-4107-A1A1-0AB67B016D28Q34568554-9A8E39DC-62FB-4273-A54B-FD3F733E1443Q34625221-87BE06E3-955A-45CC-BE99-69C13A39ED9FQ35219159-E9B5B321-C8B3-4313-9A51-CE4133787F3EQ36614506-6EE2F9C7-82FC-4AA0-9C88-1C9DAB7F9B5FQ36938143-1CD82007-D0C0-4608-8F5F-0C58C69CC8C7Q37119411-89774A7B-FE1A-487B-B386-4C5150D35E8AQ37331949-6A9B437D-71E2-4EB0-A659-904BA0002AC4Q37416391-AC7E5EB3-603F-4298-B2E7-3EC8F9DE34FAQ37468316-43E73C16-14FF-4147-8834-491B2D0A2E13Q43267049-6D9B2414-7E6F-4B90-94DA-90B2A69A12D9Q47162185-B9D07614-B9D1-41D7-9F15-80AB8F4A5AC1Q57908370-8A2B1DFF-DD61-4DFE-BB11-4CBAF8AB16C9
P2860
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@ast
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@en
type
label
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@ast
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@en
prefLabel
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@ast
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@en
P2093
P1476
Occult ovarian tumors in women ...... ing prophylactic oophorectomy.
@en
P2093
D W Cramer
J E Garber
R S Berkowitz
P304
P356
10.1200/JCO.2000.18.14.2728
P407
P577
2000-07-01T00:00:00Z